Quarterly update on the implementation of action plan to resolve the audit qualification
Filed with HKEX · Stock code 1332 · · 3 pages · English
Summary by 6ix AI
Touyun Biotech Group Limited has issued a quarterly update regarding its action plan to address an audit qualification issue. The update outlines various measures taken by the company, including launching new health products and negotiating loan extensions. Additionally, the company has successfully completed a share subscription to improve its liquidity position. The Board is committed to resolving uncertainties related to the company's going concern status and will provide further updates as necessary.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Touyun Biotech Group Limited on 6ix
Earlier from Touyun Biotech
- Grant of share options
- Notification Letter to Registered Shareholders and Reply Form - Notice of publication of 2026 Interim Report
- Notification Letter to Non-Registered Shareholders and Request Form - Notice of publication of 2026 Interim Report
- Interim report 2026
- Touyun Biotech Group Posts FY Revenue HKD 67 Million
Later from Touyun Biotech
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement entering into a cooperation agreement with Tianfu yongxing laboratory* to establish a joint research and development centre
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Touyun Biotech into a list and get an email when it puts out news.
Follow Touyun Biotech